MSA
ALNY icon

Mason Street Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History

Mason Street Advisors’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-58,620
Closed -$5.69M – 1521
2014
Q4 		$5.69M Sell
58,620
-300
-0.5% -$27.8K 0.04% 503
2014
Q3 		$4.6M Sell
58,920
-6,610
-10% -$426K 0.04% 543
2014
Q2 		$4.14M Buy
65,530
+6,380
+11% +$379K 0.03% 623
2014
Q1 		$3.97M Sell
59,150
-4,930
-8% -$382K 0.03% 611
2013
Q4 		$4.12M Buy
64,080
+4,780
+8% +$285K 0.03% 591
2013
Q3 		$3.8M Buy
+59,300
New +$2.96M 0.04% 445

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return